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Abstract
Background: Post-term pregnancy is an important factor in perinatal mortality and morbidity. Generally, to reduce perinatal mor-
tality in pregnancy, the delivery is done before adverse perinatal morbidity occurs. To prevent prolonged pregnancy, labor is induced
with chemical drugs and complementary therapies. Due to the side effects and contraindications of chemical medicine, the use of
herbs has been investigated in the induction of labor in post-term pregnancy.
Objectives: This study was done to identify the effect of chamomile on inducing labor in women with post-term pregnancy of
Shahid Akbarabadi hospital in Tehran in 2013.
Patients andMethods: This double-blind clinical trial study was performed in Iran on 80 post-term pregnant women with a gesta-
tional age of 40 weeks or more, a single pregnancy, 18 - 35 years old, cephalic presentation, an estimated fetal weight of 2500 - 4000
grams, an absence of uterine contraction, a cervical Bishop score of less than 4, the safety of the membrane, and low-risk pregnancy;
they were randomly assigned to one of two groups of 40 women. Each of the participants was given a bottle containing 42 capsules
(500 mg each) and took 2 capsules every 8 hours. The data were collected through the questionnaire of demographic observational,
and examinal characteristics. Descriptive statistics, independent samples t-test, and Fisher’s exact test using SPSS (16/win) were used
to determine and compare the effects of drugs on inducing labor in the groups.
Results: After a week of using the first dose, the results showed that in 92.5% of the chamomile group and 62.5% in the placebo
group, delivery symptoms started after taking the oral capsules, and there were significant statistical differences between the two
groups for the onset of labor (P = 0.003) There was a noticeable statistical difference between the two groups regarding the mean
interval time to the onset of labor pain after taking the capsules (P = 0.000).
Conclusions: In this study¸ chamomile stimulated labor in post-term pregnancy. With further studies, chamomile, which has no
chemical side effects, can be suggested for stimulating labor in post-term pregnancy.
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1. Background
The incidence of post-term pregnancy is 4% - 19%, which
is an important factor in perinatal mortality (1). Low-risk
pregnancy that lasts more than 42 weeks is associated with
increased perinatal mortality and morbidity (2), such as
increased fetal mortality (3, 4), metabolic acidosis of cord
blood and low Apgar scores in the fifth minutes of new-
born (5), post-maturation syndrome (6), meconium aspi-
ration syndrome (7), fetal macrosomia (8), and the results
are disordered labor, prolonged labor, dystocia, cesarean
delivery, and shoulder dystocia that increases neurological
damage and breakage in the fetus (9).
Generally, to reduce perinatal mortality in pregnancy,
delivery is done before adverse perinatal morbidity oc-
curs. To prevent prolonged pregnancy, labor is induced
with chemical drugs and complementary therapies (1).
Examples of the drugs that are used are oxytocin and
prostaglandins. These drugs, while effective in the induc-
tion of labor, have side effects such as hypertonic uter-
ine contractions and subsequent oxygen depletion to the
fetus, tearing of the cervix and uterus atonic, postpar-
tum hemorrhage, poisoning of the water, increases in ce-
sarean delivery, chorioamnionitis, nausea, vomiting, diar-
rhea, and fever (1). The stimulation of labor with chemi-
cal drugs requires hospitalization and the care of pregnant
women by trained staff, and pregnant women have to be
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confined to a bed for fetal monitoring (10).
Treatments such as aromatherapy, massage, and
herbal medicine during pregnancy and the last weeks
of the final semester of pregnancy can make women feel
more relaxed and allow the oxytocin to naturally increase
and stress hormone to decrease. As a result, spontaneous
labor starts (11-13). The use of complementary therapies
can stimulate labor and also reduce stress levels. The
use of these treatments increases uterine activity and
the satisfaction of pregnant women and their pleasant
experience during pregnancy and childbirth (14). In addi-
tion to various medical procedures used to induce labor
in post-term pregnancy, traditional methods have been
used to ease childbirth and the delivery of the fetus and
placenta, and to prevent post-term pregnancy. Many of
these methods are written in traditional Iranian medicine
books. One method is herbal medicine (15, 16).
Cedrus Libani Barrei, Caesalpinia Bonducella, Aris-
tolochi Abracteata, chamomile, Cicer arietinum, and
Dorema ammoniacum are old herbs that have been used
(15). Among these plants, chamomile has been chosen as a
tea and food spice since it is non-toxic and the most effec-
tive herb after Aristolochi Abracteata and Caesalpinia Bon-
ducella herbs (of which the toxicology is still unknown)
(17).
Since ancient times, chamomile has been used for
tonic, pain relief, nerve relief, sedation, appetite stimula-
tion, stomach stimulation, healing, and anti-viral and bac-
terial, anti-cancer, anti-anemia, and emmenagogue treat-
ment (17). Herbs such as chamomile and blue and black
Kohosh are oxytocic drugs and stimulants for uterine con-
traction (18).
As no side effects for chamomile have been reported
(15, 17, 19-22), this herb is used natively. As a result, we want
to examine whether, in comparison with common meth-
ods of labor induction, this is an effective, low-risk method.
2. Objectives
As post-term pregnancy is an important factor in peri-
natal mortality and has undesirable maternal and neona-
tal results, this study was conducted to identify the effect
of chamomile on inducing labor in women with post-term
pregnancy in Shahid Akbarabadi hospital in Tehran in 2013.
3. Patients andMethods
This study was a double-blind clinical trial conducted
on 80 primipara women, with a gestational age of preg-
nancy of 40 weeks or more, who went to the prenatal
clinic at Akbar Abadi hospital for care between July 2013
and March in 2014. Inclusion criteria for participating in
this study were as follows: 18 - 35 years of age, gestational
age of 40 weeks or more based on LMP or first-trimester
ultrasound, a single pregnancy, cephalic presentation, no
specific sickness and problems in the mother and fetus, a
live fetus, estimated fetal weight of 2500 - 4000 g based
on ultrasound or clinical examination, an absence of uter-
ine contractions, a cervical Bishop score of less than 4, the
safety of the membrane, a normal fetal heart rate upon en-
tering the study, and low-risk pregnancy (no bleeding in
the third trimester, placenta previa, abortion, fetal growth
restriction). Exclusion criteria for participating were as fol-
lows: withdrawal from the study at any stage of the study,
not referring to perinatal care, and consuming less than 3
capsules per day.
Our research community was comprised of pregnant
women who referred to the prenatal clinic of Akbar Abadi
hospital in Tehran. After obtaining permission from the
ethics committee of Tehran University of Medical Sciences
(ethical code A401/130/D/92. date 12.03.1392) and after ob-
taining permission from the faculty, research assistant, de-
partment, and nurse’s office of the hospital, the researcher
and her associate went to the prenatal clinic of the hospi-
tal every day and introduced themselves to the pregnant
women in the hospital and explained the research objec-
tives to women who were eligible for inclusion in the study.
After learning the details of the study and providing in-
formed consent, they were placed randomly in two groups,
a chamomile group and a placebo group. A demographic
questionnaire and preliminary examinations were com-
pleted. The time when each woman entered into the study
was recorded. Each of the participants was given a bottle
containing 42,500 mg capsules and took 6 capsules per day
(2 capsules every 8 hours). Participants were called every
24 hours to report on their condition. Participants were
also advised to refer to the clinic for control every other
day. Participants were given instructions to examine their
fetal movements and to go to the hospital and contact the
researcher if they had discharge, bleeding, severe abdom-
inal pain, decreased fetal movements, and abnormalities
of any kind. They were also advised that if they felt pain,
a ruptured membrane, and bleeding, to record the exact
time. When they came in for delivery, the researcher went
to them and recorded their review of all information in ex-
amination sheets and in questionnaires. The time of on-
set of drug use and delivery were recorded. All participants
were evaluated up to 7 days after entering the study. If they
did not respond to this treatment, induction and pharma-
cological interventions were initiated. Out of the 90 preg-
nant women who voluntarily entered the study, 6 women
avoided taking capsules, and 4 women took 2 capsules in a
day; thus, they were excluded from the research.
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To determine the sample size and the effective dose,
a pilot study was performed on 20 participants. After
a thorough analysis of the results using a statistical for-
mula, the sample size and the effective dose were deter-
mined. Chamomile and placebo capsules (corn starch)
were prepared and encoded in the same bottle by Tradi-
tional medicine groups of Shahed University of Medical
Sciences.
The data collection tool was a questionnaire. To deter-
mine the validity of the questionnaire, apparent and con-
tent validity were used. To determine the reliability of the
researchers, the same time observation method was used.
That is, questionnaires were made for 10 investigators and
researchers at the start of the research, and if the results
were the same, the reliability is confirmed.
The Q-square test was used for the level of education,
employment status, gestational age at the start of the
study, and the cause for admission in the hospital. We used
the Kolmogorov-Smirnov test to assess the normality of
variables. All quantitative variables had normal distribu-
tion; thus, we used the t-tests to analyze them. The inde-
pendent t-test was employed for age, body mass index, and
the interval of time between the use of the drug or placebo
and the start of labor. Fisher’s exact test was also utilized
for the onset or no onset of labor and delivery type. Data
were analyzed using SPSS version 16. For all tests, α = 0.05
was accepted for errors.
4. Results
The findings indicated no significant statistical differ-
ences between the two groups (40 pregnant women re-
ceiving chamomile versus 40 receiving a placebo only) in
terms of age, pre-pregnancy body mass index (Table 1),
education, employment, and gestational age upon enter-
ing the study (Table 2). After a week of using the first
dose, in 92.5% of the chamomile group and 62.5% of the
placebo group, delivery symptoms started after taking the
oral capsules. Statistical analyses revealed significant sta-
tistical differences between the chamomile and placebo
groups for the onset of labor (P = 0.003) (Table 3). The per-
centage of women showing symptoms of labor was 48.6%
in the chamomile group and 52% in the placebo group
who referred to the hospital with painful uterine contrac-
tions and 43.62% in the chamomile group and 44% in the
placebo group who complained of uterine contractions
and a ruptured membrane. In Table 4, the reasons for re-
ferring to the hospital’s emergency room are shown. Out
of 37 women in the chamomile group and 25 women in the
placebo group who entered in the delivery phase, the in-
terval of time between entering the study to the start of la-
bor was 62.705 hours in the chamomile group and 106.456
hours in the placebo group. This difference was significant
(P = 0.000) (Table 5).
Table 1. Demographic Data (Age, Pre-Pregnancy Body Mass Index) of the Groups
Groups Chamomile Placebo P Value
Age, y 24.42± 4.76 24.57± 3.75 0.876
BMI, kg/m2 22.55± 2.009 22.53± 2.109 0.973
Table 2. Demographic Characteristics (Education, Employment, and Gestational
age at Enrollment) of the Groupsa
Group Chamomile Placebo P Value
Education 0.633
Without education 1 (2.5) 1 (2.5)
Elementary and middle
school
11 (27.5) 13 (32.5)
High school diploma 25 (62.5) 20 (50)
University 3 (7.5) 6 (15)
Employment 0.5
Home work 40 (100) 39 (97.5)
Employed 0 (0) 1 (2.5)
Gestational age at enrollment 0.943
40 Weeks 18 (45) 18 (45)
40 weeks and 1 day 10 (25) 9 (22.5)
40 weeks and 2 days 11 (27.5) 11 (27.5)
40 weeks and 3 days 1 (2.5) 2 (5)
aValues are expressed as No. (%).
Table 3. Onset of Labor in the Two Groups
Groups Chamomile Placebo P Value (Fisher’s Exact Test)
Yes 37 (92.5) 25 (62.5) 0.003
No 3 (7.5) 15 (37.5) 0.003
5. Discussion
This research was done to study the effect of
chamomile on inducing delivery in post-term preg-
nancy. The findings showed that labor started in 92.5%
of the chamomile group and 62.5% of the placebo group
one week from the start of taking capsules (P = 0.003).
A double-blind clinical study was done by Yargholi et al.
(23) to explore the effect of chamomile herbal tea during
pregnancy on childbirth in the term pregnancy. Little
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Table 4. Reason for Admission for Delivery in the Two Groups
Groups Chamomile Placebo P Value
Onset of regular uterine
contractions
18 (48.6) 13 (52) 0.88
Onset of regular uterine
contractions and decreased fetal
movement
2 (5.4) 1 (4) 0.88
Onset of regular uterine
contractions and ROM
16 (43.62) 11 (44) 0.88
Onset of regular uterine
contractions , decreased
movement and bleeding
1 (2.7) 0 0.88
Abbreviation: ROM, rupture of membrane.
Table 5. Interval of Time Between Taking Capsules and the Onset of Labor Symptoms
(Hours)
Groups Mean± SD P Value
Chamomile 62.705± 32.556 0.000
Placebo 106.456± 24.475 0.000
difference was observed in gestational age in the time of
delivery (after the consumption of herbal tea) between
the chamomile and placebo groups (P = 0.689). In spite of
the lack of significant statistical differences between the
two groups, this study found that post-term pregnancy
in the placebo group was more than chamomile group.
Burns et al. in 2003 (19) conducted a study with the aim
of investigating the therapeutic effects of aromatherapy
with oils of chamomile, sage, frankincense, lavender, and
mandarin on delivery outcomes in Italy. This study rep-
resented no significant statistical difference between the
two groups in initiating spontaneous labor. The results of
these studies differed from ours.
Our findings indicate that the mean interval time of
the start of labor pain after taking the capsules was 62.705
± 32.556 hours in the chamomile group and 106.456 ±
24.475 hours in the placebo group. This showed that the
gestational age at the time of delivery in the chamomile
group was shorter than the placebo group. The indepen-
dent t-test results indicated a noticeable statistical differ-
ence between the two groups in terms of the interval time’s
mean onset of labor (P = 0.000). No other studies have
shown the time of labor induction, which may be because
of the limited number of studies in this field.
As one of the consequences of post-term pregnancy is
stress and fear due to the failure to initiate labor (24), the
stress and anxiety can increase the amount of adrenalin
and adrenocorticotropic hormone release. These materi-
als are anti-oxytocic, or anti-uterine contraction, and thus
delay delivery (13). The use of relaxing treatment by reduc-
ing the levels of adrenalin and noradrenalin and remov-
ing the inhibitory effects of adrenalin and increasing oxy-
tocin can increase miometrial functions and uterine con-
tractions (13). After the release of oxytocin, the time and
severity of contractions increase; in addition, chamomile
is a relaxing plant (17). Herbs such as chamomile and blue
and black cohosh are known uterine-stimulating drugs
and have an oxytocic effect (18). According to this study, it
seems that this herb can induce labor in post-term preg-
nancy.
It is suggested that clinical trial studies be done by
comparing with common procedures. Laboratory studies
should be done to investigate the biochemical effects of
chamomile on the control of uterine contractions. Other
studies with various pharmaceutical forms of chamomile
can be undertaken. Surveys should be conducted to com-
pare the effect of chamomile with syntocinon and other in-
terventions.
Our study had several limitations. First, it was done on
pregnant women in one hospital who were probably not
the suitable representatives of all of pregnant women, and
the results cannot be generalized to all post-term pregnant
women. In addition, women in this hospital were from
certain socioeconomic classes. Some of the factors influ-
encing pain intensity, such as culture and nutrition, were
uncontrollable. It seems that certain factors, such as cul-
ture and awareness of people, influenced the use of herbal
medicine and the onset of labor. This study was performed
at an educational hospital that had uncontrolled and high
interventions for patients, which may have affected the re-
sults of the study.
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